Advertisement
News
Advertisement

Watson To Pay $18 mln to Elan in Settlement

Mon, 03/09/2009 - 5:05am
CORONA, Calif. (AP) — Watson Pharmaceuticals Inc. said Friday it will pay $18 million to Elan Corp. PLC to settle a patent lawsuit over Watson's generic version of pain reliever Naprelan, or naproxen sodium tablets. Watson also agreed not to marke t or sell its naproxen sodium product until the expiration of the patent on the drug. It did not say when the patent would expire, be found invalid or unenforceable.
Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading